Steven D. Fidanze,Dachun Liu,Robert A. Mantei,Keith F. McDaniel,John Pratt,George S. Sheppard,Le Wang,Andrew Bogdan,James H. Holms,Justin D. Dietrich,Jasmina Marjanovic,Lisa A. Hasvold,Yujia Dai
申请号：
US16827026
公开号：
US20200291027A1
申请日:
2020.03.23
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides for compounds of formula (I)wherein R1, R2, R6, Y1, Y2, Y3, A1, A2, A3, and A4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula (I).
